CN Patent

CN1655782A — 治疗眼部疾病的罗氟司特的眼科应用

Assigned to AstraZeneca AB · Expires 2005-08-17 · 21y expired

What this patent protects

本发明描述了用于治疗眼部疾病的含有罗氟司特的药物制剂。

USPTO Abstract

本发明描述了用于治疗眼部疾病的含有罗氟司特的药物制剂。

Drugs covered by this patent

Daliresp (ROFLUMILAST) · Arcutis

Patent Metadata

Patent number: CN1655782A
Jurisdiction: CN
Classification: —
Expires: 2005-08-17
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.